Dr. Ladan Eshkevari will be speaking on the “Efficacy of Addition of IV Glutathione to Standard Ketamine IV Therapy in Major Depressive Disorder”, the topic of the research study conducted at Avesta Ketamine and Wellness Clinics and published to the Psychiatry Research publication. The session will be held on January 25th at 11am. Please reach out if you’d like to learn more!
Deborah is co-CEO of Avesta Ketamine and Wellness. She is dedicated to improving the patient experience and to expanding access for cutting-edge mental health treatments for patients suffering from treatment-resistant depression, generalized anxiety, PTSD and other mood disorders.
Take the first step to healing. Speak with one of our experienced intake coordinators to:
Check out our featured articles on Ketamine Wellness
Written by Deborah Tan. Medically reviewed by Dr. Ladan Eshkevari, CRNA, PhD, FAAN. Yes, for…...
Written by Deborah TanMedically reviewed by Dr. Ladan Eshkevari, CRNA, PhD, FAAN Does TRICARE cover ketamine treatment?…...
Written by Deborah TanMedically reviewed by Dr. Ladan Eshkevari, CRNA, PhD, FAAN VA ketamine treatment is covered,…...
